Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > I would like to see TH endorse NASH

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Feb 16, 2021 2:06pm

69 Views

Post# 32575213

RE:RE:I would like to see TH endorse NASH

Rusty I will refer you to a post a couple months ago I highly doubt that the panel that Thera has with loomba, grinspoon ect would campaign so hard if nash wasn't a real legit opportunity

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing